Upload
verity-douglas
View
226
Download
13
Tags:
Embed Size (px)
Citation preview
Technische Universität München
Cancer biomarker discovery by chemical and quantitative
proteomics
Sebastian Berger, B. Sc., 3010425
Center of Life and Food Sciences Weihenstephan
Chair of Proteomics and Bioanalytics
Master Kolloquium
Content
Introduction
Methods
Results
Discussion
Einführung
Cancer:
•A major cause of death
•Lung Cancer (85% NSCLC)
Cancer establishment:
•6 hallmarks of cancer
•No exact pathway
Einführung
Biomarkers:
•Since antiquity
•DNA biomarker
•Protein biomarker
– e.g. Kinase
Discovery:
•Needle in the haystack
Einführung
Aim:
•Kinase as biomarker
To-Do:
•Healthy vs. Cancer
•Kinase enrichment
•Quantification
Methods
Workflow:
• Tissue lysis
• Affinity pulldown
• LC-MS/MS
• Quantification
• Identification
• Statistical analysis
Kinome enrichment
Methods
Affinity pulldown:
•Kinobeads
– Kinase inhibitors
Protein Quantification
•Progenesis LC-MS
– Intensity based quantification
Results
Results
Quantification method comparison
Ergebnisse
Reproducibility
•Correlation Coefficient
•All identified kinases
•Kinases with >3 peptides for quantification
•Higher reproducibility in the higher intensity part
Sample Correlation [1/2] Correlation [1/2] >3
15 57.70 86.89
16 85.6 91.8
18 91.3 94.38
21 90 93.91
33 75 85
36 37.2 73.33
56 48 54.35
57 55 75.42
62 81 93.19
65 80 98
86 89 90
87 89 97.66
90 87.44 92.95
97 78.30 90.70
121 53.2 70.96
122 71 90.27
127 87,4 95.38
Results
Data Evaluation
•Progenesis data
•VSN normalized data
•QQ-Plots
– Straight line indicates normal distribution
•Scatter plots
Progenesis
VSN data
Results
Progenesis VSN
Results
PCA Analysis
•Progenesis data
A: Proteins B: Cancer Control
Results
PCA Analysis
•VSN data
A: Proteins B: Cancer Control
Results
Kinase Clustering
Progenesis VSN
Results
Ingenuity Pathway
Results
Kinase profiling
Results
Patient profiling
Discussion
Quantification
•Only „Chemical labeling“ or label-free
Sample Exclusion
•Cancer Sample 33
•Cancer Sample 36
•Control Sample 62
50 kD
C 33E 33C 36E 36C 56
C 33E 33C 36E 36C 56E 56HOP 62E 62
75 kD
50 kD
Sample Correlation [1/2] Correlation [1/2] >3
36 37.2 73.33
Discussion
Kinase profiling
•Overall expression
Patient profiling
•Stratification
IPA
•Pathway prediction
Discussion
Sample type
•Biopsy
•Blood
Outlook
Further screening
Not yet diseased
Smokers vs. Non-smokers
Therapy context
Blood sample
Thank you for your attention!